Abstract:Abstract Disclosure: S. Sathi: None. M. Jara-Tantoco: None. C. Anastasopoulou: None. Background: Allgrove syndrome, initially described as a triad of alacrimia, adrenal insufficiency (AI), and esophageal achalasia (Triple A syndrome) is a multisystem disorder with a wide array of phenotypic presentations. Mutations involving the AAAS (achalasia-addisonianism-alacrimia syndrome) gene on chromosome 12q13 are the cause with a prevalence of 1 in 1 million population. To our knowledge, there are no reports of any other endocrine manifestations apart from AI and osteoporosis associated with this disorder. We describe a patient with a cluster of more endocrine diseases. Case: A 44-year-old hispanic female was diagnosed with Allgrove syndrome in the first decade of her life when she was found to have esophageal achalasia, AI, and absence of lacrimation. Physical exam revealed BMI of 18 kg/m2 without dysmorphic features, skin abnormalities, or neurological deficits. Thyroid gland size was within normal limits, and there was no evidence of thyroid eye disease. She had multiple hospitalizations with abdominal symptoms attributed to esophageal stricture and esophagitis resulting in an adrenal crisis each time. During one such hospitalization, she had symptoms suggesting hyperthyroidism including palpitations, weight loss, and heat intolerance. Workup was consistent with Graves’ disease, and she was started on methimazole 5 mg daily with good response. Further evaluation revealed that she became amenorrheic in her 20s. Workup was consistent with premature ovarian failure (POF). A DXA scan revealed very low bone mineral density consistent with osteoporosis (T scores; Hip: -3.8, Fem neck: -3.7, Lumbar Spine: -3.5). She had mild vitamin D deficiency but normal calcium and parathyroid hormone levels. The patient chose osteoporosis-specific treatment over hormonal replacement. Zoledronic acid was chosen considering her history of Heller myotomy and esophageal strictures. She was maintained on hydrocortisone 20 mg daily for her adrenal insufficiency. Lab work: FSH: 148 mIU/ml (3.5 - 12.5)LH: 58.4 mIU/ml (2.4 - 12.5)Estradiol: <5 pg/mL (12.5 - 166)TSH: <0.01 mIU/mL(0.35 - 4.94)T4 Free: 2.45 ng/dL (0.7 - 1.48)TSI %: 412(<140)PTH: 17 pg/mL (15 - 65)Learning points: Allgrove syndrome is a rare autosomal recessive inherited disorder with 70% of the patients developing the classic triad of alacrimia, esophageal achalasia, and AI. Early onset osteoporosis that is not completely explained by glucocorticoid use, has been described. We present a patient with Allgrove syndrome with additional disorders of hyperthyroidism and POF which are known risk factors for osteoporosis. It is unclear if these additional endocrine abnormalities are manifestations of Allgrove syndrome or just coincidental. Further evaluation of known cases of Allgrove syndrome for these disorders can help answer this question. Presentation: 6/3/2024

SCARB1 downregulation in adrenal insufficiency with Allgrove syndrome

Mutation Analysis of AAAS Gene in a Child with Allgrove Syndrome

7333 Does Allgrove Syndrome Have Endocrine Manifestations Beyond Adrenal Insufficiency?

Proteomic Landscape of Aldosterone-Producing Adenoma

Prevalence and clinical features of armadillo repeat-containing 5 mutations carriers in a single center cohort of patients with bilateral adrenal incidentalomas

GENETICS IN ENDOCRINOLOGY: Glucocorticoid resistance syndrome

Allelic Variants of ARMC5 in Patients With Adrenal Incidentalomas and in Patients With Cushing's Syndrome Associated With Bilateral Adrenal Nodules

Clinical and Gene Mutation Studies on a Chinese Pedigree with Glucocorticoid-Remediable Aldosteronism.

Cardiovascular and metabolic risk factors in patients with subclinical Cushing

Aldosterone synthase gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in normal male subjects

Aldosterone-Producing Adenoma With a Somatic KCNJ5 Mutation Revealing APC-Dependent Familial Adenomatous Polyposis

Morphologic and Molecular Characterization of Adrenals and Adrenal Rest Affected by Congenital Adrenal Hyperplasia

Polymorphism in the Drug Transporter Gene ABCB1 as a Potential Disease Modifier in Cortisol-Producing Adrenal Adenomas

Enhanced chronic inflammation and increased branched chain amino acids in adrenal disorders: a cross-sectional study

Discovery of a Cushing's syndrome protein kinase A mutant that biases signaling through type I AKAPs

Activating hotspot L205R mutation in PRKACA and adrenal Cushing’s syndrome

Predisposing factors for adrenal crisis in chronic adrenal insufficiency: a case-control study

Activating Hotspot L205R Mutation in PRKACA and Adrenal Cushing's Syndrome.

A Rare Case of Unilateral Adrenal Hyperplasia Accompanied by Hypokalaemic Periodic Paralysis Caused by a Novel Dominant Mutation in CACNA1S: Features and Prognosis after Adrenalectomy

Biallelic NDC1 variants that interfere with ALADIN binding are associated with neuropathy and triple A-like syndrome

The molecular genetics of adrenal cushing